Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool)
- PMID: 35948412
- PMCID: PMC11372759
- DOI: 10.1136/bmjebm-2022-111944
Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool)
Abstract
Background: Network meta-analysis (NMA) is increasingly used in guideline development and other aspects of evidence-based decision-making. We aimed to develop a risk of bias (RoB) tool to assess NMAs (RoB NMA tool). An international steering committee recommended that the RoB NMA tool to be used in combination with the Risk of Bias in Systematic reviews (ROBIS) tool (i.e. because it was designed to assess biases only) or other similar quality appraisal tools (eg, A MeaSurement Tool to Assess systematic Reviews 2 [AMSTAR 2]) to assess quality of systematic reviews. The RoB NMA tool will assess NMA biases and limitations regarding how the analysis was planned, data were analysed and results were presented, including the way in which the evidence was assembled and interpreted.
Objectives: Conduct (a) a Delphi process to determine expert opinion on an item's inclusion and (b) a knowledge user survey to widen its impact.
Design: Cross-sectional survey and Delphi process.
Methods: Delphi panellists were asked to rate whether items should be included. All agreed-upon item were included in a second round of the survey (defined as 70% agreement). We surveyed knowledge users' views and preferences about the importance, utility and willingness to use the RoB NMA tool to evaluate evidence in practice and in policymaking. We included 12 closed and 10 open-ended questions, and we followed a knowledge translation plan to disseminate the survey through social media and professional networks.
Results: 22 items were entered into a Delphi survey of which 28 respondents completed round 1, and 22 completed round 2. Seven items did not reach consensus in round 2. A total of 298 knowledge users participated in the survey (14% respondent rate). 75% indicated that their organisation produced NMAs, and 78% showed high interest in the tool, especially if they had received adequate training (84%). Most knowledge users and Delphi panellists preferred a tool to assess both bias in individual NMA results and authors' conclusions. Response bias in our sample is a major limitation as knowledge users working in high-income countries were more represented. One of the limitations of the Delphi process is that it depends on the purposive selection of experts and their availability, thus limiting the variability in perspectives and scientific disciplines.
Conclusions: This Delphi process and knowledge user survey informs the development of the RoB NMA tool.
Keywords: evidence-based practice; health care quality, access, and evaluation; health services research; methods.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: AAV was an Associate Editor for the journal, but was not involved with the decision or peer-review process.
Figures


Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Analysis of risk of bias assessments in a sample of intervention systematic reviews, Part II: focus on risk of bias tools reveals few meet current appraisal standards.J Clin Epidemiol. 2024 Oct;174:111460. doi: 10.1016/j.jclinepi.2024.111460. Epub 2024 Jul 16. J Clin Epidemiol. 2024. PMID: 39025376
-
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849. BMJ. 2022. PMID: 35944924 Free PMC article.
-
Accommodation-based interventions for individuals experiencing, or at risk of experiencing, homelessness.Campbell Syst Rev. 2021 May 18;17(2):e1165. doi: 10.1002/cl2.1165. eCollection 2021 Jun. Campbell Syst Rev. 2021. Update in: Campbell Syst Rev. 2020 Sep 08;16(3):e1103. doi: 10.1002/cl2.1103. PMID: 37131929 Free PMC article. Updated. Review.
Cited by
-
Exploring decision-makers' challenges and strategies when selecting multiple systematic reviews: insights for AI decision support tools in healthcare.BMJ Open. 2024 Jul 5;14(7):e084124. doi: 10.1136/bmjopen-2024-084124. BMJ Open. 2024. PMID: 38969371 Free PMC article.
-
Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels.Front Immunol. 2025 Jan 23;15:1510145. doi: 10.3389/fimmu.2024.1510145. eCollection 2024. Front Immunol. 2025. PMID: 39916953 Free PMC article.
-
Risk of Bias in Network Meta-Analysis (RoB NMA) tool.BMJ. 2025 Mar 18;388:e079839. doi: 10.1136/bmj-2024-079839. BMJ. 2025. PMID: 40101916 Free PMC article.
-
Assessing the methodological quality and risk of bias of systematic reviews: primer for authors of overviews of systematic reviews.BMJ Med. 2024 May 30;3(1):e000604. doi: 10.1136/bmjmed-2023-000604. eCollection 2024. BMJ Med. 2024. PMID: 38826514 Free PMC article. No abstract available.
-
A novel way to integrate economic information into clinical practice guidelines.BMC Health Serv Res. 2024 Nov 16;24(1):1415. doi: 10.1186/s12913-024-11891-3. BMC Health Serv Res. 2024. PMID: 39548485 Free PMC article.